en

PRODUCT DETAIL

Carboplatin Kabi 10 mg/ml

Code 0072A
MA number 44/0165/12-S
Product Form: con inf 1x60 ml/600 mg (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Fresenius Kabi s.r.o., Czechia
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XA Platinum compounds
L01XA02 Carboplatin
Shelf life: 24
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 21.03.2012
SPC: SPC_Carboplatin Kabi 10 mg_ml_07.2024.pdf  
PIL: PIL_Carboplatin Kabi 10 mg_ml_07.2024.pdf  
Safety feature Yes
Data update: 29.05.2018
eu-flag.png sk-flag.png